- Home
- HYNE vs CLNN Comparison
HYNE vs CLNN Comparison
Compare HYNE & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HYNE | CLNN |
|---|---|---|
| Founded | 2025 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 112.1M | 120.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | HYNE | CLNN |
|---|---|---|
| Price | $14.39 | $4.05 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $32.67 |
| AVG Volume (30 Days) | 42.3K | ★ 91.8K |
| Earning Date | 01-01-0001 | 03-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $13,191,325.00 | $214,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $82.05 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 13.86 | N/A |
| 52 Week Low | $13.35 | $2.28 |
| 52 Week High | $14.85 | $13.50 |
Technical Indicators
Market Signals| Indicator | HYNE | CLNN |
|---|---|---|
| Relative Strength Index (RSI) | 47.39 | 37.28 |
| Support Level | $14.00 | $3.96 |
| Resistance Level | $14.49 | $4.60 |
| Average True Range (ATR) | 0.28 | 0.39 |
| MACD | -0.03 | 0.05 |
| Stochastic Oscillator | 32.86 | 17.52 |
Price Performance
Historical ComparisonAbout HYNE Hoyne Bancorp Inc.
Hoyne Bancorp Inc is a holding company that conducts business mainly through its subsidiaries. It is a savings institution focused on serving customers' banking needs in the market area. The group offers Personal and Business banking services.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.